BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Covington
Cerilliant
Daiichi Sankyo
Accenture
Fish and Richardson
Moodys
Chinese Patent Office
Merck

Generated: January 20, 2018

DrugPatentWatch Database Preview

ETOPOSIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for etoposide and what is the scope of etoposide patent protection?

Etoposide
is the generic ingredient in four branded drugs marketed by Mylan, Dava Pharms Inc, Accord Hlthcare, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Corden Pharma, and Bristol Myers Squibb, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for etoposide. Six suppliers are listed for this compound.
Pharmacology for ETOPOSIDE
Medical Subject Heading (MeSH) Categories for ETOPOSIDE

US Patents and Regulatory Information for ETOPOSIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pierre Fabre ETOPOSIDE etoposide INJECTABLE;INJECTION 074813-001 Jul 9, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ETOPOPHOS PRESERVATIVE FREE etoposide phosphate INJECTABLE;INJECTION 020906-001 Feb 27, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd ETOPOSIDE etoposide INJECTABLE;INJECTION 204927-001 Oct 31, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dava Pharms Inc VEPESID etoposide CAPSULE;ORAL 019557-002 Dec 30, 1986 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa ETOPOSIDE etoposide INJECTABLE;INJECTION 074284-001 Feb 10, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ETOPOSIDE etoposide INJECTABLE;INJECTION 074228-001 Oct 15, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ETOPOSIDE etoposide INJECTABLE;INJECTION 074351-001 Aug 30, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Inc ETOPOSIDE etoposide INJECTABLE;INJECTION 074968-001 Jan 9, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dava Pharms Inc VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ETOPOSIDE etoposide INJECTABLE;INJECTION 074320-001 Aug 30, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ETOPOSIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dava Pharms Inc VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 ➤ Subscribe ➤ Subscribe
Dava Pharms Inc VEPESID etoposide CAPSULE;ORAL 019557-002 Dec 30, 1986 ➤ Subscribe ➤ Subscribe
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Daiichi Sankyo
Citi
Harvard Business School
Cantor Fitzgerald
Moodys
Boehringer Ingelheim
Queensland Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot